| Schedule of Computation of Basic and Diluted Earnings per Share |
The following table illustrates the computation of basic and diluted earnings per share (in thousands, except per share amounts): | | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended
June 30, | | Six Months Ended
June 30, | | | 2024 | | 2023 | | 2024 | | 2023 | | Numerator - Basic | | | | | | | | | Net income (loss) | $ | 152,716 | | | $ | 56,199 | | | $ | 163,893 | | | $ | 190,706 | | | Noncontrolling interests’ share in earnings | (6,669) | | | (4,300) | | | (11,170) | | | (19,855) | | | Net income (loss) attributable to Healthpeak Properties, Inc. | 146,047 | | | 51,899 | | | 152,723 | | | 170,851 | | Less: Participating securities’ share in earnings | (214) | | | (149) | | | (414) | | | (1,402) | | | Net income (loss) applicable to common shares | $ | 145,833 | | | $ | 51,750 | | | $ | 152,309 | | | $ | 169,449 | | | | | | | | | | | | | | | | | | | | | | | | | | | Numerator - Dilutive | | | | | | | | | Net income (loss) applicable to common shares | $ | 145,833 | | | $ | 51,750 | | | $ | 152,309 | | | $ | 169,449 | | | Add: distributions on dilutive convertible units and other | 71 | | | — | | | 36 | | | — | | | Dilutive net income (loss) available to common shares | $ | 145,904 | | | $ | 51,750 | | | $ | 152,345 | | | $ | 169,449 | | | Denominator | | | | | | | | | Basic weighted average shares outstanding | 702,382 | | | 547,026 | | | 651,642 | | | 546,936 | | Dilutive potential common shares - equity awards(1) | 135 | | | 268 | | | 157 | | | 268 | | | | | | | | | | Dilutive potential common shares - OP Units(2) | 751 | | | — | | | 314 | | | — | | | | | | | | | | | Diluted weighted average common shares | 703,268 | | | 547,294 | | | 652,113 | | | 547,204 | | | Earnings (loss) per common share | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Basic | $ | 0.21 | | | $ | 0.09 | | | $ | 0.23 | | | $ | 0.31 | | | Diluted | $ | 0.21 | | | $ | 0.09 | | | $ | 0.23 | | | $ | 0.31 | |
_______________________________________ (1)For all periods presented, represents the dilutive impact of 1 million outstanding equity awards (restricted stock units and stock options). (2)For the three and six months ended June 30, 2024, represents the dilutive impact of 3 million outstanding OP Units.
|